Boyds, a leading consultancy business supporting the development of pharmaceutical and biotech products for patient benefit, has opened an office in Dublin, Ireland in a step that will ensure the continuity of service to its clients once the UK leaves the EU on 29th March.
Boyds, which has headquarters in Crewe, and expanded into new premises outside Cambridge early last year, now employs 20 members of staff.
The new office will be based at DCU Invent on the Dublin City University Campus.